ScienceAugust 25, 2026
tafamidis
tuh-FAM-ih-dis
Definition
A pharmacological compound used as a therapeutic drug to treat amyloidosis by stabilizing transthyretin proteins to prevent them from misfolding and clumping.
Etymology
This term is a modern pharmaceutical name constructed using established chemical naming conventions, where the suffix '-idis' is typically employed to denote a drug class or specific therapeutic agent.
In the news
Tafamidis is identified as the active ingredient in the FDA-approved drugs Vyndamax and Vyndaqel, which were developed based on Jeffery Kelly's research into preventing protein aggregation.
Scripps Research professor Jeffery Kelly elected to the European Academy of Engineering
Read the full article ↗Scripps Research